These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1673 related items for PubMed ID: 27725146

  • 1. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J, Derrien M, Törnblom H, Brazeilles R, Cools-Portier S, Doré J, Störsrud S, Le Nevé B, Öhman L, Simrén M.
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [Abstract] [Full Text] [Related]

  • 2. Lactulose Challenge Determines Visceral Sensitivity and Severity of Symptoms in Patients With Irritable Bowel Syndrome.
    Le Nevé B, Brazeilles R, Derrien M, Tap J, Guyonnet D, Ohman L, Törnblom H, Simrén M.
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):226-33.e1-3. PubMed ID: 26492847
    [Abstract] [Full Text] [Related]

  • 3. Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation.
    Parthasarathy G, Chen J, Chen X, Chia N, O'Connor HM, Wolf PG, Gaskins HR, Bharucha AE.
    Gastroenterology; 2016 Feb; 150(2):367-79.e1. PubMed ID: 26460205
    [Abstract] [Full Text] [Related]

  • 4. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N, Ringel Y, Katibian D, Lundqvist A, Sartor RB, Carroll IM, Ringel-Kulka T.
    Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
    [Abstract] [Full Text] [Related]

  • 5. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.
    Shukla R, Ghoshal U, Dhole TN, Ghoshal UC.
    Dig Dis Sci; 2015 Oct; 60(10):2953-62. PubMed ID: 25784074
    [Abstract] [Full Text] [Related]

  • 6. An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila.
    Cruz-Aguliar RM, Wantia N, Clavel T, Vehreschild MJGT, Buch T, Bajbouj M, Haller D, Busch D, Schmid RM, Stein-Thoeringer CK.
    Digestion; 2019 Oct; 100(2):127-138. PubMed ID: 30423561
    [Abstract] [Full Text] [Related]

  • 7. Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects.
    Sundin J, Stridsberg M, Tap J, Derrien M, Le Nevé B, Doré J, Törnblom H, Simrén M, Öhman L.
    Sci Rep; 2018 Nov 14; 8(1):16821. PubMed ID: 30429499
    [Abstract] [Full Text] [Related]

  • 8. Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.
    Li G, Yang M, Jin Y, Li Y, Qian W, Xiong H, Song J, Hou X.
    J Gastroenterol Hepatol; 2018 Jun 14; 33(6):1220-1226. PubMed ID: 29194775
    [Abstract] [Full Text] [Related]

  • 9. Understanding of the Site-Specific Microbial Patterns towards Accurate Identification for Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Zhu X, Hong G, Li Y, Yang P, Cheng M, Zhang L, Li Y, Ji L, Li G, Chen C, Zhong C, Jin Y, Yang M, Xiong H, Qian W, Ding Z, Ning K, Hou X.
    Microbiol Spectr; 2021 Dec 22; 9(3):e0125521. PubMed ID: 34937163
    [Abstract] [Full Text] [Related]

  • 10. Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome.
    Sundin J, Aziz I, Nordlander S, Polster A, Hu YOO, Hugerth LW, Pennhag AAL, Engstrand L, Törnblom H, Simrén M, Öhman L.
    Sci Rep; 2020 Jan 17; 10(1):593. PubMed ID: 31953505
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives.
    Chen J, Lan H, Li C, Xie Y, Cheng X, Xia R, Ke C, Liang X.
    J Appl Microbiol; 2024 Jun 03; 135(6):. PubMed ID: 38849305
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.
    Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A.
    Gastroenterology; 2007 Jul 03; 133(1):24-33. PubMed ID: 17631127
    [Abstract] [Full Text] [Related]

  • 19. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T, Hausken T, Hov JR, Valeur J, Sangnes DA, El-Salhy M, Gilja OH, Hatlebakk JG, Lied GA.
    Scand J Gastroenterol; 2019 Jun 03; 54(6):690-699. PubMed ID: 31190584
    [Abstract] [Full Text] [Related]

  • 20. Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption.
    Jeffery IB, Das A, O'Herlihy E, Coughlan S, Cisek K, Moore M, Bradley F, Carty T, Pradhan M, Dwibedi C, Shanahan F, O'Toole PW.
    Gastroenterology; 2020 Mar 03; 158(4):1016-1028.e8. PubMed ID: 31843589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 84.